TL;DR
This study reveals that a circular RNA, circ_0023984, is significantly upregulated in esophageal squamous cell carcinoma (ESCC) and promotes tumor progression. It achieves this by acting as a "sponge" for miR-134-5p, thereby releasing the inhibition of cystatin-S (CST4) expression, a protein that also contributes to ESCC malignancy. This circRNA-miRNA-protein axis presents a potential therapeutic target for ESCC.
What Problem Does This Paper Address?
Esophageal cancer (EC), particularly esophageal squamous cell carcinoma (ESCC), is a highly aggressive malignancy with a poor prognosis. While research has identified circular RNAs (circRNAs) as potential players in cancer, the specific role of circ_0023984 in ESCC progression remained unclear. This paper aims to elucidate the functional significance of circ_0023984 in ESCC, specifically investigating its impact on cell growth, invasion, and migration, and to uncover the molecular mechanisms by which it exerts its oncogenic effects.
Methods
The researchers employed a multi-pronged approach to investigate circ_0023984's role:
- Expression Analysis: Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure circ_0023984 levels in ESCC tissues and cell lines, as well as in normal counterparts.
- Subcellular Localization: Subcellular fractionation assays were performed to determine whether circ_0023984 is primarily located in the nucleus or cytoplasm, which is crucial for understanding its interaction with other molecules.
- Loss-of-Function Studies: Lentivirus-mediated shRNA knockdown was used to stably reduce circ_0023984 expression in ESCC cell lines.
- Functional Assays: A suite of standard cell-based assays were conducted to assess the impact of circ_0023984 knockdown on:
- Cell Proliferation: Cell Counting Kit-8 (CCK-8) and 5-Ethynyl-2'-deoxyuridine (EDU) incorporation assays.
- Colony Formation: Colony formation assays.
- Migration and Invasion: Transwell migration and invasion assays.
- Molecular Interaction Studies:
- RNA Pull-down Assay: To confirm direct binding between circ_0023984 and miR-134-5p.
- Luciferase Reporter Assay: To validate the interaction and functional consequence of miR-134-5p binding to circ_0023984 and CST4.
- RNA Immunoprecipitation (RIP) Assay: To assess the co-enrichment of circ_0023984 and miR-134-5p with AGO2 protein, indicating their presence in the RNA-induced silencing complex (RISC).
- In Vivo Tumorigenesis Model: Subcutaneous tumor models in nude mice were established to evaluate the role of circ_0023984 and CST4 in tumor growth.
- Western Blotting (WB): Used to assess protein expression levels, particularly for CST4.
- Immunohistochemistry (IHC): Performed on tumor sections to evaluate the expression of proliferation markers (Ki-67) and CST4.
Datasets
- GEO Dataset GSE131969: This dataset was used for initial analysis of circ_0023984 expression in ESCC tissues and normal samples.
- TCGA Dataset: Utilized via the Starbase online tool to assess CST4 mRNA expression in ESCC patients.
- Clinical Samples: Tissues from 70 ESCC patients and paired paraneoplastic tissues were collected and analyzed.
Key Insights and Ideas
- Circ_0023984 as an Oncogenic Driver: The study strongly suggests that circ_0023984 is not just upregulated but actively drives ESCC progression. Its knockdown significantly impairs key malignant phenotypes.
- The "Sponging" Mechanism: The research confirms that circRNAs can act as miRNA sponges. Circ_0023984 effectively "sequesters" miR-134-5p, preventing it from performing its normal regulatory functions.
- A Novel Regulatory Axis: The identification of the circ_0023984/miR-134-5p/CST4 axis is a significant contribution, linking a circRNA to a specific miRNA and a downstream protein target that is also implicated in cancer.
- CST4's Oncogenic Role: The study highlights that CST4 itself plays a role in promoting ESCC, and its upregulation is a consequence of circ_0023984's action.
- Therapeutic Potential: The findings point towards circ_0023984 and potentially the miR-134-5p/CST4 axis as promising targets for future ESCC therapies.
Key Results
- Upregulation in ESCC: Circ_0023984 was found to be significantly upregulated in ESCC tissues and cell lines compared to normal controls.
- Poor Prognosis Correlation: High expression of circ_0023984 in ESCC patients was associated with significantly poorer overall survival.
- Suppression of Malignancy: Knockdown of circ_0023984 in ESCC cells led to reduced proliferation, colony formation, migration, and invasion.
- Interaction with miR-134-5p: Circ_0023984 directly interacts with miR-134-5p, and its knockdown leads to increased miR-134-5p levels.
- miR-134-5p Targets CST4: miR-134-5p was shown to target the 3'UTR of CST4 mRNA, negatively regulating its expression.
- CST4 Overexpression Rescues Effects: Overexpression of CST4 could partially rescue the suppressive effects of circ_0023984 knockdown on cell proliferation, migration, and invasion.
- In Vivo Tumor Inhibition: Knockdown of circ_0023984 significantly inhibited tumor growth in nude mice, and CST4 overexpression partially restored tumor growth in these models.
Limitations and Future Work
- Mechanism of circ_0023984 Upregulation: The paper acknowledges that the precise mechanisms driving the upregulation of circ_0023984 in ESCC require further investigation.
- Broader miRNA Interactions: While the study focused on miR-134-5p, circRNAs can interact with multiple miRNAs. Future work could explore other potential miRNA targets of circ_0023984.
- Clinical Translation: While promising, the findings are preclinical. Further research is needed to translate these discoveries into effective clinical therapies for ESCC patients.
- Detailed Molecular Pathways: While the miR-134-5p/CST4 axis is identified, the downstream signaling pathways influenced by CST4 in ESCC could be further elucidated.
Summary updated